May 23, 5:10 AM EDT
Media & Culture
Instant view: U.S. advisers say keep Glaxo's Avandia on market
By IBT Staff Reporter on 07/14/10 AT 6:40 PM
U.S. health advisers voted on Wednesday to keep GlaxoSmithKline's Avandia diabetes drug on the market, with a majority of those in favor recommending the treatment carry additional warnings.